A detailed history of New York State Teachers Retirement System transactions in Xencor Inc stock. As of the latest transaction made, New York State Teachers Retirement System holds 58,226 shares of XNCR stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,226
Previous 58,526 0.51%
Holding current value
$1.49 Million
Previous $1.11 Million 5.69%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$15.7 - $21.65 $4,710 - $6,495
-300 Reduced 0.51%
58,226 $1.17 Million
Q4 2023

Jan 24, 2024

SELL
$16.53 - $21.42 $4,959 - $6,426
-300 Reduced 0.51%
58,526 $1.24 Million
Q3 2023

Oct 25, 2023

SELL
$20.08 - $25.39 $12,047 - $15,234
-600 Reduced 1.01%
58,826 $1.19 Million
Q2 2023

Jul 27, 2023

SELL
$24.77 - $29.9 $4,954 - $5,980
-200 Reduced 0.34%
59,426 $1.48 Million
Q1 2023

Apr 27, 2023

SELL
$25.95 - $36.95 $23,355 - $33,255
-900 Reduced 1.49%
59,626 $1.66 Million
Q3 2022

Oct 28, 2022

BUY
$24.62 - $32.44 $2,462 - $3,244
100 Added 0.17%
60,526 $1.57 Million
Q2 2022

Aug 01, 2022

BUY
$19.74 - $29.01 $1,973 - $2,901
100 Added 0.17%
60,426 $1.65 Million
Q1 2021

Apr 22, 2021

SELL
$40.81 - $53.88 $110,187 - $145,476
-2,700 Reduced 4.28%
60,326 $2.6 Million
Q3 2020

Nov 06, 2020

BUY
$30.09 - $43.02 $21,063 - $30,114
700 Added 1.12%
63,026 $0
Q4 2019

Jan 24, 2020

BUY
$32.75 - $41.43 $262,163 - $331,647
8,005 Added 14.74%
62,326 $2.14 Million
Q3 2019

Oct 24, 2019

BUY
$33.73 - $46.27 $1.83 Million - $2.51 Million
54,321 New
54,321 $1.83 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.53B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.